Company intelligence / Profile preview

Advent Access

Singapore, Singapore

Ownership: Private
Development stage: Other

Overview

Advent Access is a Singapore-based medical device spin-off from A*STAR developing a novel vascular access solution for hemodialysis; available information focuses on technology and financing rather than formal clinical trial phases, but the company positions its product as a next-generation access option and has attracted strategic and venture backing.[4][6]

Therapeutic areas: Nephrology
Modalities: DeviceNon-pharmacological therapy
Industry: Implantable Medical Devices

Partnerships

Agency for Science, Technology and Research (A*STAR) spin-off relationship and commercialization support via its technology transfer arm (ETPL, now A*ccelerate)[6]Stanford StartX accelerator community membership, providing access to Silicon Valley mentor and investor networks[4]

Beyond the preview

Go deeper on Advent Access.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Advent Access.

Explore the full profile